Skip to main content
Cytogen, Inc. logo

Cytogen, Inc. — Investor Relations & Filings

Ticker · 217330 ISIN · KR7217330000 KO Manufacturing
Open in API
Filings indexed 436 across all filing types
Latest filing 2025-01-15 Legal Proceedings Report
Country KR South Korea
Listing KO 217330

About Cytogen, Inc.

https://www.cytogenlab.com/

Cytogen, Inc. is a biotechnology company specializing in liquid biopsy platforms for precision oncology. The company has developed proprietary technology for the rapid isolation and analysis of viable Circulating Tumor Cells (CTCs) from whole blood. Its core offering, the SmartBiopsy Platform, utilizes a high-density microporous chip with microfluidics and nanotechnology to capture CTCs efficiently. This non-invasive diagnostic approach is designed to support early cancer detection, treatment monitoring, and the advancement of personalized medicine for cancer patients.

Recent filings

Filing Released Lang Actions
불성실공시법인지정 (공시불이행)
Legal Proceedings Report Classification · 100% confidence The document is a formal regulatory notice from the KOSDAQ market regarding the designation of a company (Cytogen) as an 'unfaithful disclosure corporation' due to a failure to disclose litigation. This is a regulatory announcement concerning compliance and penalties, which falls under the category of general regulatory filings.
2025-01-15 Korean
조회공시요구(현저한시황변동)에대한답변(미확정)
Regulatory Filings Classification · 100% confidence The document is a formal response to a stock exchange's request for disclosure regarding significant market fluctuations (unusual stock price movement). It provides updates on pending corporate matters, such as board composition changes and shareholder proposals, and sets a deadline for further disclosure. As this is a standard regulatory disclosure requirement in the Korean market (KRX) that does not fit into specific categories like M&A or financial reporting, it is classified as a general regulatory filing.
2025-01-08 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% report or major shareholding notification). It details changes in share ownership by a specific individual (Kim Jin-wook) in the company 'Cytogen'. This falls under the category of Major Shareholding Notification.
2025-01-07 Korean
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the change of the company's CEO (Representative Director). It details the outgoing CEO, the incoming co-CEOs, the reason for the change (resignation), and the date of the board resolution. This falls directly under the category of board/management changes.
2025-01-02 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 95% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is explicitly marked as a '정정신고' (Correction Report). It details changes to stock option grants, including adjustments to the number of shares and the list of recipients due to resignations. This type of disclosure regarding stock-based compensation and capital structure changes falls under the category of general regulatory filings as it does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for new capital issuance). Therefore, it is classified as a Regulatory Filing (RNS).
2025-01-02 Korean
[기재정정]주식매수선택권부여에관한신고
Remuneration Information Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is a correction (정정신고) of a previous filing. It details changes to the board of directors and specific adjustments to stock option grants for employees. Since this document relates to corporate governance and regulatory reporting of share-based compensation and management changes, but does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for capital changes), it falls under the general regulatory filing category.
2025-01-02 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.